Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23623)

• Formulation Name: Amikacin eq 250mg injectable
• Company: Teva Parenteral Medicines

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Amikacin	(DM5PDRB)	Bacteremia	1A73	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Sodium citrate dihydrate	(E00369)	71474	Alkalizing agent; Buffering agent; Complexing agent; Emulsifying agent
Sodium hydroxide	(E00234)	14798	Alkalizing agent
Sodium metabisulfite	(E00444)	656671	Antimicrobial preservative; Antioxidant
Sulfuric acid	(E00045)	1118	Acidulant
Water	(E00035)	962	Solvent